University of Cincinnati

Institute for Supply Management® Announces 2024 R. Gene Richter Scholarship Winners

Retrieved on: 
Thursday, March 28, 2024
Organization, University, Stanley Black, Memory, Wayne State University, Hewlett-Packard, University of Cincinnati, IBM, University of South Carolina, Student, Pennsylvania State University, Creativity, ISM, Stanley Black & Decker, Management

TEMPE, Ariz., March 28, 2024 /PRNewswire/ -- Institute for Supply Management® (ISM®) has selected the 2024 recipients of the R. Gene Richter Scholarship, an award presented annually to the top supply management students from across the United States. Recipients were determined based upon a submitted essay, cumulative grade point average, demonstrated leadership, extracurricular involvement, and overall achievements as an undergraduate professional, including through internships and case competitions.

Key Points: 
  • TEMPE, Ariz., March 28, 2024 /PRNewswire/ -- Institute for Supply Management® (ISM®) has selected the 2024 recipients of the R. Gene Richter Scholarship, an award presented annually to the top supply management students from across the United States.
  • We truly believe they will grow to become leaders in supply management," said Nancy Richter, founder of the R. Gene Richter Scholarship Program.
  • The R. Gene Richter Scholarship Program was established and named in memory of R. Gene Richter, who was a galvanizing force in the field of procurement.
  • For information on the R. Gene Richter Scholarship Program and the 2024 winners, visit: richterfoundation.org , and ismworld.org/awards .

ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination

Retrieved on: 
Wednesday, March 6, 2024
Infection, Bangladesh Technical Education Board, CD4, Superior, Hepatitis B, Headache, CpG, Fungal infection, NIAID, CROI, ACTG, University of Cincinnati, Weill Cornell Medicine, Conference, Vaccination, University, ART, Fatigue, Virus, Myalgia, White, Black, Protocol, UM1, Massachusetts General Hospital, Male, Hepatitis, HIV, University of North Carolina, Vaccine

These data demonstrated that the HepB-CpG vaccine achieved up to 99 percent protection among people living with HIV who had previously not responded to conventional hepatitis B vaccines, a noteworthy increase compared to the protection achieved by conventional vaccines.

Key Points: 
  • These data demonstrated that the HepB-CpG vaccine achieved up to 99 percent protection among people living with HIV who had previously not responded to conventional hepatitis B vaccines, a noteworthy increase compared to the protection achieved by conventional vaccines.
  • People living with HIV, especially those with lower CD4 counts, often do not develop protective antibodies after receiving conventional hepatitis B vaccines.
  • The HepB-CpG (HEPLISAV-B®) vaccine includes a TLR-9 agonist adjuvant (CpG 1018® adjuvant) and is known to achieve high protection against hepatitis B among people living with HIV, but until now there have been limited data about its protection among people living with HIV who have not responded to conventional hepatitis B vaccines.
  • “Hepatitis B remains a significant issue for people living with HIV, as having both viruses increases the likelihood of liver complications,” said ACTG Chair Judith Currier, M.D., M.Sc., University of California Los Angeles.

Spencer Fane Enters Nation’s Second Largest Legal Market with Patent Litigation Group

Retrieved on: 
Wednesday, February 28, 2024
Wake Forest University, Metallurgy, IAM, University, United States district court, International trade, Culture, District court, West Virginia University, Invention, Smartphone, Virginia University, Patent, University of Cincinnati, Intellectual property, Law, IP, Juris, Telecommunications, Chemical engineering, Semiconductor, Justice, Robotics, Software, Wilfrid Sellars

The trio joins the firm’s growing Intellectual Property practice while also giving Spencer Fane a foothold in the second-largest legal market in the U.S.

Key Points: 
  • The trio joins the firm’s growing Intellectual Property practice while also giving Spencer Fane a foothold in the second-largest legal market in the U.S.
  • The group joins a Spencer Fane IP team that possesses both the technical knowledge and legal experience necessary to protect inventors, entrepreneurs, and businesses of all sizes.
  • She has litigated patent cases for over 20 years, including as co-lead counsel in over ten lawsuits that went to trial.
  • Holley has managed all aspects of patent litigation including pre-filing diligence, claim construction, fact and expert discovery, dispositive motions, and trial.

Universal Display Corporation Announces the Appointment of New Board Members

Retrieved on: 
Thursday, March 7, 2024
Research, Professional Services, Hardware, Consumer Electronics, Alternative Energy, Apps, Applications, Energy, Technology, Semiconductor, Science, Nanotechnology, Finance, University, Doctor of Philosophy, Biotechnology, Cystic fibrosis, Investment, General partnership, UDC, Health, MBA, Brandywine Realty Trust, OLED, Business, Open University, Rockwell Medical, Organization, Biological engineering, Partner (business rank), University of Cincinnati, Lighting, LLP, Rothschild & Co, BDN, Universal Display Corporation, Management

Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have joined the Company’s Board of Directors, effective March 4, 2024.

Key Points: 
  • Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced that Dr. Nigel Brown and Dr. Joan Lau have joined the Company’s Board of Directors, effective March 4, 2024.
  • The addition of these new directors expands UDC’s Board to ten members.
  • “I am pleased to welcome Nigel and Joan to the Board,” said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation and a member of the Board.
  • “Nigel adds a wealth of business innovation, technical knowledge and corporate strategic planning expertise to our Board.

Cincinnati Children's names Bob Carpenter senior vice president and chief legal officer

Retrieved on: 
Tuesday, February 27, 2024
University of Cincinnati, Senior, Liability (financial accounting), Health care, University, History, Hanover College, MD, Risk management, Management

CINCINNATI, Feb. 27, 2024 /PRNewswire/ -- Cincinnati Children's has named Bob Carpenter senior vice president and chief legal officer.

Key Points: 
  • CINCINNATI, Feb. 27, 2024 /PRNewswire/ -- Cincinnati Children's has named Bob Carpenter senior vice president and chief legal officer.
  • "Bob is a trusted leader with proven expertise in corporate governance, risk management, litigation and compliance."
  • An employee of the health system since 2006, Carpenter joins the 11-person Executive Team led by Steve Davis, MD, president and chief executive officer of Cincinnati Children's.
  • He succeeds Rosland Fisher McLeod, who recently left after having been chief legal officer since 2022.

Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024

Retrieved on: 
Wednesday, February 14, 2024
Fibromyalgia, Tonix Pharmaceuticals, FDA, Pain, Food, Sleep, Behavioral neuroscience, Hope, Hydrogen chloride, University, Fatigue, Patient, University of Cincinnati, University of Michigan, Psychiatry, Tablet, NDA, KOL, Pharmaceutical industry

CHATHAM, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, held a key opinion leader (KOL) webinar to discuss the positive Phase 3 data of Tonmya™ (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia, and the path to file for FDA approval in the second half of 2024. The webinar was held on January 31, 2024 and hosted by Alliance Global Partners (A.G.P.).

Key Points: 
  • The webinar was held on January 31, 2024 and hosted by Alliance Global Partners (A.G.P.).
  • As previously announced, Tonix’s second positive Phase 3 study, RESILIENT, met its pre-specified primary endpoint, significantly reducing daily pain compared to placebo (p=0.00005) in participants with fibromyalgia.
  • Tonix plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2024 for Tonmya™ for the management of fibromyalgia.
  • “We are now an important step closer to bringing a new, first-line treatment to fibromyalgia patients that offers broad symptom relief and favorable tolerability for chronic use and adherence.”

University of Cincinnati and Virtual Internships Forge Partnership to Expand Student Opportunities

Retrieved on: 
Tuesday, January 30, 2024
Partnership, Cooperative education, Internship, Student, College, University, Information technology, Professional studies, Faculty, UC, University of Cincinnati, Associate

CINCINNATI, Ohio, Jan. 30, 2024 (GLOBE NEWSWIRE) -- University of Cincinnati (UC), known as the birthplace of cooperative education, has announced a new partnership with Virtual Internships to enable information technology students to access global work experience.

Key Points: 
  • CINCINNATI, Ohio, Jan. 30, 2024 (GLOBE NEWSWIRE) -- University of Cincinnati (UC), known as the birthplace of cooperative education, has announced a new partnership with Virtual Internships to enable information technology students to access global work experience.
  • Erik Alanson, Interim Unit Head and Associate Professor at UC overseeing the collaboration, said, "By joining forces with Virtual Internships, we are opening doors for our students beyond the Greater Cincinnati region.
  • Daniel Nivern, CEO of Virtual Internships, highlighted the significance of the partnership, saying, "Virtual Internships is thrilled to unite with a true industry leader.
  • For further details on how Virtual Internships collaborates with universities to enhance internship access, visit www.virtualinternships.com/universities .

ORISE report shows overall number of health physics degrees decreases to lowest level in decades

Retrieved on: 
Wednesday, January 31, 2024
Research, Other Energy, Engineering, Manufacturing, Energy, Continuing, University, Science, Education, Other Science, Oregon State University, Health physics, Government, University of Tennessee, Georgetown University, DOE, Employment, Bloomsburg University of Pennsylvania, University of Cincinnati, San Diego State University, Student, Purdue University, Data collection, Nursing

According to the report, 21 students received bachelor’s degrees with majors in health physics in 2022 and 19 in 2021—the lowest numbers of bachelor’s degrees reported since 1973, the inception of the ORISE health physics survey.

Key Points: 
  • According to the report, 21 students received bachelor’s degrees with majors in health physics in 2022 and 19 in 2021—the lowest numbers of bachelor’s degrees reported since 1973, the inception of the ORISE health physics survey.
  • The number of health physics master’s degrees awarded in 2022 decreased by 27 percent and 25 percent from 2021 and 2019 levels, respectively.
  • The number of doctorate degrees awarded in health physics in 2022 is the second lowest number reported since 1966.
  • Oregon State University had the largest number of health physics degrees awarded in 2021 and 2022 with 6 bachelor’s degrees and 59 master’s degrees, followed by Purdue University and the Illinois Institute of Technology.

University of Nebraska, Lincoln Takes Top Honors at 22nd Annual Deloitte FanTAXtic National Case Study Competition

Retrieved on: 
Tuesday, January 30, 2024
Well, Student, Learning, University at Albany, SUNY, University of Houston, University, Champaign, Illinois, San Diego State University, School, University of Massachusetts, Faculty, Florida International University, University of Cincinnati, University of Utah, University of Mississippi, Depreciation, Creativity, University of California, Jackson State University, University of Tennessee, University of Nebraska–Lincoln, Lincoln, University of Florida, University of Illinois Urbana-Champaign, University of Southern California

NEW YORK, Jan. 30, 2024 /PRNewswire/ -- A team of students from University of Nebraska, Lincoln, claimed victory at the Deloitte FanTAXtic national case study competition by presenting the best analysis on a complex, issues-driven business tax case. This year's case challenged teams to provide advice on how to structure a new business entity and help determine whether they should operate the venture as an S corporation or a C corporation. Teams were also asked to share advice on tax issues like how to calculate depreciation, when to recognize income, and how to calculate a specific business income deduction. The national finals were held Jan. 19-21 at Deloitte University, Deloitte's landmark campus for learning and leadership development in Westlake, Texas.

Key Points: 
  • NEW YORK, Jan. 30, 2024 /PRNewswire/ -- A team of students from University of Nebraska, Lincoln, claimed victory at the Deloitte FanTAXtic national case study competition by presenting the best analysis on a complex, issues-driven business tax case.
  • The national finals were held Jan. 19-21 at Deloitte University, Deloitte's landmark campus for learning and leadership development in Westlake, Texas.
  • The other teams that participated were: Florida International University; San Diego State University; University at Albany; University of California, Los Angeles; University of Cincinnati; University of Florida; University of Houston; University of Illinois, Urbana – Champaign; University of Massachusetts; University of Mississippi; University of Southern California; University of Tennessee; and University of Utah.
  • Each of the 16 teams participating in the national competition won the Deloitte FanTAXtic contest in their respective U.S. regions.

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P.

Retrieved on: 
Thursday, January 25, 2024
Fibromyalgia, Psychiatry, KOL, Behavioral neuroscience, University, University of Cincinnati

CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced a key opinion leader (KOL) webinar to discuss the positive Phase 3 data of TNX-102 SL for the management of fibromyalgia.

Key Points: 
  • CHATHAM, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced a key opinion leader (KOL) webinar to discuss the positive Phase 3 data of TNX-102 SL for the management of fibromyalgia.
  • The webinar will feature two esteemed thought leaders in the field of fibromyalgia and will be hosted by Alliance Global Partners.
  • Lesley Arnold, M.D., Professor of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine